Biden Admin Using DPA To Bring 60M At-Home COVID-19 Tests To Market

By Kelly Lienhard / February 5, 2021 at 2:52 PM

The federal government has directed six different manufactures to ramp up domestic production of non-prescription, at-home COVID-19 tests under the Defense Production Act, the White House’s COVID-19 Response Team revealed Friday (Feb. 5).

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.

FEATURES

NEWSLETTERS

ABOUT US

Inside Health Policy is a subscription-fee-based daily digital news service from Inside Washington Publishers.

SITE LICENSES

Economical site license packages are available to fit any size organization, from a few people at one location to company-wide access. For more information on how you can get greater access to Inside Health Policy for your office, contact Online Customer Service at 703-416-8505 or healthpolicy@iwpnews.com.

STAY CONNECTED

Biden Admin Using DPA To Bring 60M At-Home COVID-19 Tests To Market

Log in to access this content.

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.